chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left arm pain; limited mobility; Initial information received on 03-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a female patient of unknown demography who experienced left arm pain (pain in extremity) and limited mobility (mobility decreased), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, following the vaccination the patient experienced left arm pain (pain in extremity) and limited mobility (mobility decreased).  (Other relevant tests included no lab data.)  Final diagnosis was pain in arm and mobility decreased.  It was not reported if the patient received a corrective treatment.  The outcome of the events was unknown at the time of reporting.  Information on the batch number was requested.  List of documents held by sender: none.
A couple months, February 2022, after the vaccine, I started noticing my nose staying stuffed up, my ears felt stuffed up then started draining. I put drops in it like I normally do, this time it did not help, I went back to the ENT where I had gotten the ear drops, he put a slit in my ear to drain the fluid, he put a tube in my right ear. This seems to have helped so far. I have lost taste and smell from where I had COVID-19 back in 2020. I am going to research group that is working with people who have long-haul COVID-19
The patient has had persistent right shoulder pain which is worsened by activity since receiving her COVID-19 vaccination in March 2021. On exam, moderate right glenohumeral and exquisite subacromial tenderness was noted which is suggestive of subacromial bursitis. It is possible that this is a Shoulder Injury Related to Vaccine Administration (SIRVA). The patient is unable to tolerate NSAIDs, so will treat topically with Voltaren gel.
This spontaneous report as received from a 75 year old male patient refers to himself. Patients medical history, drug reactions and allergies reported as none. Approximately on an unknown date in 2011, (two to three years ago), the patient was vaccinated with ZOSTAVAX Subcutaneous Injection, (dose, frequency were unspecified). Concomitant therapy included unspecified many medications (names, dose and manufacturers were unspecified). On 15-JAN-2014, the patient was diagnosed with shingles. The patient sought medical attention, visited physicians office. The patient was treated with ACYCLOVIR, dose and manufacturer unspecified. No lab diagnostics studies were performed. The patient's blisters have scabbed over, but he was still experiencing itchiness and nerve pain. No other symptoms were provided. No product quality complaint was involved. The outcome of shingles was reported as not recovered. The reporters causality assessment for the event shingles with the therapy of ZOSTAVAX was not reported. No further information was provided. Additional information has been requested.
Moderate to severe muscular  pain starting in upper thighs bilaterally and spreading to entire thigh over the course  of several days.  I am a fit woman who walks 3 miles 3-4 times a week. I did not participate in any activity that would have caused this issue.  Several of my colleagues that were vacinated. In December and January have also been complaining of unusual muscle  and joint aches so I thought I should report.
Client received 1st dose of Moderna vaccine at 1:30 pm and at approximately 7:00 pm she experienced loss of muscle strength/weakness of her left arm along with edema from the left elbow down to the left wrist. No pain was associated with the event. The swelling and weakness resolved itself the next day, within 24 hours of the onset of symptoms.
ON 3RD DAY: sore/swollen lymph nodes left side of neck and jaw, with some mild discomfort in left ear; lasted about 3 hours; I applied a warm compress and the symptom subsided and has not returned
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A female patient received the 3rd (booster) dose of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st and 2nd dose of the COVID-19 vaccine (manufacturer unknown), Mar 2021 and Apr 2021, for COVID-19 immunization. The patient had pain/it was a little sore, with outcome of unknown. The lot number for BNT162B2 not provided and will be requested during follow-up.
Information has been received from a physician concerning PO with the second dose of Rotateq (human-bovine). Concomitant therapy included ZANTAC and PREVACID. The physician reported that on approximately 04-JAN-2007, within five hours of being vaccinated, the patient developed GERD. Unspecified medical attention was sought. No laboratory/diagnostic tests were performed. At the time of the report, the patient was noted to be recovering. Additional information has been requested.
Pfizer vaccine was not diluted properly- not enough diluent was used Call was placed to check in with patient, patient is currently sleeping. I was able to speak with wife who is on HIPPA,  patient seems "ok", "tired and sore" which are both expected side effects from second vaccine per the EUA document. Informed to call if any issues arise, wife states understanding.
Code red was sent and when I arrived the pt was on the exam table with generalized tonic clonic seizure last for 30 sec then pt went into a post ictal state for 1 minute.
Flared up on forearms and lasted for 3 days; Had quite a bit of itching on arms and next to hands; Swollen on backs of hands, had redness, took a week to 10 days for redness to go away; She believes this was an allergic reaction; Swollen on backs of hands, had redness, took a week to 10 days for redness to go away; 1-2 hours after, broke out with a rash on backs of both hands; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Flared up on forearms and lasted for 3 days), PRURITUS (Had quite a bit of itching on arms and next to hands), PERIPHERAL SWELLING (Swollen on backs of hands, had redness, took a week to 10 days for redness to go away), HYPERSENSITIVITY (She believes this was an allergic reaction) and ERYTHEMA (Swollen on backs of hands, had redness, took a week to 10 days for redness to go away) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Psoriasis. Concomitant products included ROSUVASTATIN, HYDROXYCHLOROQUINE, AMLODIPINE, METFORMIN, CARVEDILOL, WARFARIN, ISOSORBIDE MONONITRATE, POTASSIUM CHLORIDE (KLOR-CON), FUROSEMIDE, CINNAMON [CINNAMOMUM VERUM] and VITAMINS NOS for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PSORIASIS (Flared up on forearms and lasted for 3 days), PRURITUS (Had quite a bit of itching on arms and next to hands), PERIPHERAL SWELLING (Swollen on backs of hands, had redness, took a week to 10 days for redness to go away), HYPERSENSITIVITY (She believes this was an allergic reaction), ERYTHEMA (Swollen on backs of hands, had redness, took a week to 10 days for redness to go away) and RASH (1-2 hours after, broke out with a rash on backs of both hands). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CLOBETASOL at an unspecified dose and frequency. At the time of the report, PSORIASIS (Flared up on forearms and lasted for 3 days), PRURITUS (Had quite a bit of itching on arms and next to hands), PERIPHERAL SWELLING (Swollen on backs of hands, had redness, took a week to 10 days for redness to go away), HYPERSENSITIVITY (She believes this was an allergic reaction), ERYTHEMA (Swollen on backs of hands, had redness, took a week to 10 days for redness to go away) and RASH (1-2 hours after, broke out with a rash on backs of both hands) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt's right arm was swollen, red, and hot to touch. Pt stated right arm was itchy. Recommended pt to take BENADRYL and MOTRIN/ADVIL or ALEVE. Recommended pt to contact her physician as soon as possible.
PCV-7 vaccine given in L thigh am of 7/9. Parents noted redness and swelling around vaccine site that evening. Child noted to have scratched area around injection site. Next day, L thigh redness & swelling increased with increased warmth and hardness.  Oral antibiotics started 7/11/01.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age.  No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication.  On or about 19-MAY-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) vaccine (lot number, dosage, vaccination site and route of administration were not provided), as recommended for routine adult health maintenance for the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered a very painful rash on the left chest spreading to the back. The patient was diagnosed with shingles. As a direct and proximate result of the Company's defective zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms have resulted in physical limitations not present prior to using the Company's product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), The patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was not recovered. The causality was related.   The event of shingles was considered to be disabling.
Moderna COVID-19 Vaccine EUA 0300 on the 10th, flu-like symptoms, headache, 100.8 fever, complete body ache, dizzy spells complete bed rest, hydrate, soup, TYLENOL 0900 on the 11th, fever has returned to normal, some body ache remains, dizzyness has subsided
Patient vomited at 12:30 a.m. (15 hours after receiving 1st dose of COVID vaccine). He vomited regularly until 4:30 a.m., for a total of 7 times (last 3 times didn't produce much vomit).
Patient went to multiple County clinic locations and received multiple vaccines. The information provided was of different names, addresses, and other information. No adverse effects have been reported at this time.
Recv'd first shot 4/3/21, was fine 4/4/21. Early in AM of 4/5/21 I had muscle aches, stomach cramping, and chills. At 1 point I stopped working because I felt tingly, and started to sweat (only happened once). I'm feeling tired, like I have the flu.
Patient presented with refusal to eat and no stool or urine output for more than 6 hours. She was referred to ER, where she was found to be hypertensive and lethargic. Transferred to another hospital where she was diagnosed with myocarditis and heart failure. She was started on Milrinone and LASIX. Within 3 days she recovered. Viral respiratory panel was negative. Cause of myocarditis was not discovered.
Had shingles were vaccinated / Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (had chickenpox as kid).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had shingles were vaccinated / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 22-MAR-2023 This case was reported by patients' daughter member via  interactive digital media. The reporter reported that his or her father had shingles after received Shingles vaccine. The reporter figuring the vaccine will not do good for him or her as well. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. This case had been linked with US2023AMR058207 by same reporter for different patient.; Sender's Comments:  US-GSK-US2023AMR058207:same reporter
Sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A. and 042E21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced ILLNESS (Sick). In May 2021, ILLNESS (Sick) had resolved.            Concomitant information was not provided.  It was reported that patient was sick for 2 days and took almost one week to be back to normal.  Treatment information was not provided.   This case was linked to MOD-2021-404385 (Patient Link).
He had some pain on his shoulder; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's wife) reported that a male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date it was reported that caller and his wife had 1st dose today. He had some pain on his shoulder after 1st dose and his wife had Tylenol prior her 1st dose. Outcome of the event was unknown.
My left breast/nipple have become enlarged and sore to the touch; My left breast/nipple have become enlarged and sore to the touch.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 02May2021 at 15:00(at the age of 60-years-old) as a single dose for COVID-19 immunisation. The medical history included Crohn's disease. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the  left arm on 11Apr2021 at 15:00(at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 09May2021 at 07:00, the patient's left breast/nipple had become enlarged and sore to the touch. On 21Sep2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events left breast/nipple had become enlarged and sore to the touch were not resolved at the time of this report.
Broke out in red, itchy hives all over body (face, neck, arms, stomach, back, legs) 1 week after second Pfizer shot.  Took over-the-counter antihistamines for 2 weeks.  Started experiencing lip swelling 2 weeks after shot and scheduled tele-health visit with primary doctor.  Prescribed 10-day course of Prednisone early May and continued taking OTC medicine.  Hives returned 1 week after completing Prednisone course (5/15).  Lip swelling occurred again 5/29 and referred to urgent care clinic where 7-day course of Hydroxizine was prescribed which had no effect on hives.  Continued OTC medicine until able to meet with allergist, Doctor on 7/7. (see contin pg)
I have never had an adverse reaction to the flu vaccine. I started feeling bad about 9pm with a dry throat. By 10 pm, I had a headache and nausea. Around 12pm I had the dry heaves. For the rest of the night I slept and woke up with a cold sweat. The next day I had a low grade fever (99.8) until 9pm
Patient became light headed and blacked out, did not know where he was.  Indicated his right eye was red and swollen.
Patient received Moderna vaccine 4/8/21, and then she received the Pfizer vaccine 4/21/21.
Patient reports received first Pfizer covid vaccine 1Apr2021 2nd 15Apr2021; right thumb has been stiff and locking up seceral times and increased pain; right thumb has been stiff and locking up seceral times and increased pain; almost like a dislocation or tendon slipped; almost like a dislocation or tendon slipped; headaches; almost like a dislocation or tendon slipped; This is a spontaneous report from a contactable or other Health Care Professional (nurse). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 15Apr2021 (at the age of 43-years-old) as dose 2, single for COVID-19 immunization and received first of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 01Apr2021 (at the age of 43-years-old) as dose 1, single for COVID-19 immunization. It was unknown that the patient was pregnant at the time of vaccination. The patient's medical history included ligament sprain from 2013 to an unknown date, migraines related to hormonal changes, diarrhoea from Feb2021 to an unknown date. The patient's concomitant medications included tofacitinib citrate (XELJANZ XR, Batch/Lot number was not reported; Expiration Date: 28Feb2023) from oral route on 19Feb2021 to an unspecified date as 11 mg daily tablet for an unspecified indication. Any medications patient was using around the time of adverse event and dates of therapy [exclude medications used to treat event] include OTC and herbals was unknown. On unspecified date patient reports received first Pfizer covid vaccine 01Apr2021 and second dose on 15Apr2021 missed doses one week before and one week after dose after resuming right thumb has been stiff and locking up several times and increased pain states almost like this location are tendon slipped. Patient stated she has had issues with six to eight years ago and had received a cortisone shot in area also reports the area first 12 weeks of starting cells and it has subsided. Patient had headache. The outcome of the events was unknown.Follow-up attempts completed. No further information is expected.Amendment: This follow-up report is being submitted to amend previously reported information: updated Xeljanz XR to concomitant medication. Sender's Comments: Linked Report(s) : US-PFIZER INC-2021591696.
Patient has pre-existing multiple sclerosis. Developed new neurological symptoms consistent with flare of multiple sclerosis 5 days after vaccine administered. Also flu-like symptoms with fever, myalgias and sore throat. Seen by neurologist. Treated with TAMIFLU, IV and oral steroids. Slowly improving over 2 weeks time.
I developed multiple migraine headaches days and weeks after the vaccine after not having any migraine episodes for years prior.; I have also been continuing to experience long lasting muscle and joint pain/weakness, to the point where my knees feel unsteady or unstable while walking.; I have also been continuing to experience long lasting muscle and joint pain/weakness, to the point where my knees feel unsteady or unstable while walking.; I have also been continuing to experience long lasting muscle and joint pain/weakness, to the point where my knees feel unsteady or unstable while walking.; I have also been continuing to experience long lasting muscle and joint pain/weakness, to the point where my knees feel unsteady or unstable while walking.; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Mar2021 at 10:30 (at the age of 32-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient developed multiple migraine headaches days and weeks after the vaccine after not having any migraine episodes for years prior. From an unknown date in Mar2021, the patient also has been continuing to experience long lasting muscle and joint pain/weakness, to the point where his knees feel unsteady or unstable while walking. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events developed multiple migraine headaches days and weeks after the vaccine after not having any migraine episodes for years prior; continuing to experience long lasting muscle and joint pain/weakness, to the point where his knees feel unsteady or unstable while walking was not  resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cold Chills Muscle aches Heart rate 110-150BPM for 5-6 hours that started approx 36hrs after the vaccine was administered Axillary swelling the size a baseball, swelling was also noted in left pectoral muscle and in left shoulder blade